Vas Narasimhan (Photographer: Simon Dawson/Bloomberg via Getty Images)
New buyers lining up bids for Novartis' giant generics arm
With the fate of Novartis’ generics unit up in the air, more potential buyers are reportedly lining up for what could be one of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
